Samuel “Sam” Geisler, a partner with the firm, focuses his practice primarily in complex civil product liability litigation, including the Preterm Infant Formula NEC and Recalled Abbott Formula Litigations as well as in several medical device litigations, including Essure, 3m Defective Earplugs and vaginal mesh. He is among those leading the effort against Skanska USA Civil Southeast on behalf of Pensacola region business owners and individuals who suffered losses as a result of the Pensacola Bay Bridge outage.

District Judge Matthew Kennelly recently appointed Mr. Geisler as Co-Lead counsel in the In Re: Recalled Abbott Infant Formula Product Liability Litigation now pending in the Northern District of Illinois. Mr. Geisler has tried cases to jury verdict and served on the trial team responsible for a historic $9 billion verdict against Takeda Pharmaceutical Co. and Eli Lilly & Co. involving their drug, Actos. He served as a lead trial counsel representing local businesses who successfully denied Skanska’s bid to avoid responsibility for the Pensacola Bay Bridge outage.  That matter is now on appeal.  He serves on the Plaintiff Steering Committee for the Essure litigation before Senior District Judge John R. Padova and the co-chair of the Xarelto MDL Regulatory Discovery Committee. Mr. Geisler has served on trial teams for each of three Xarelto bellwether trials in federal court before District Judge Eldon Fallon and two Xarelto bellwether trials in Pennsylvania state court.

He earned a Juris Doctorate from the Saint Louis University School of Law where he received Saint Louis University’s Student Legal Writers Association’s Writing Excellence Award. Also while attending law school, his law journal comment, “A Bridge to Somewhere: How a Bolder Causal Analysis Can Shape Civil RICO into the Ideal Free Market Safeguard,” was selected for publication and appeared in the Saint Louis University Law Journal.  More recently, he co-authored an article published in the Suffolk University Law Review with R. Jason Richards, titled “We, the Class: What the Founding Generation Can Tell Us About Adequate Representation in Class Action Litigation.”